PXS4728A: Phase Ib data

Data from 24 healthy volunteers in the Phase Ib portion of the double-blind, placebo-controlled, Australian Phase Ia/Ib PXS-4728A-101 trial showed that once-daily 3-10 mg oral PSX-4728A for 14 days we...